BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33021900)

  • 1. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sickle Cell Disease Ontology: enabling universal sickle cell-based knowledge representation.
    Sickle Cell Disease Ontology Working Group
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31769834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sickle Cell Disease Ontology: recent development and expansion of the universal sickle cell knowledge representation.
    Mazandu GK; Hotchkiss J; Nembaware V; Wonkam A; Mulder N
    Database (Oxford); 2022 Apr; 2022():. PubMed ID: 35363306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease.
    Mulder N; Nembaware V; Adekile A; Anie KA; Inusa B; Brown B; Campbell A; Chinenere F; Chunda-Liyoka C; Derebail VK; Geard A; Ghedira K; Hamilton CM; Hanchard NA; Haendel M; Huggins W; Ibrahim M; Jupp S; Kamga KK; Knight-Madden J; Lopez-Sall P; Mbiyavanga M; Munube D; Nirenberg D; Nnodu O; Ofori-Acquah SF; Ohene-Frempong K; Opap KB; Panji S; Park M; Pule G; Royal C; Sangeda R; Tayo B; Treadwell M; Tshilolo L; Wonkam A
    Appl Transl Genom; 2016 Jun; 9():23-9. PubMed ID: 27354937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
    Hegemann L; Narasimhan V; Marfo K; Kuma-Aboagye P; Ofori-Acquah S; Odame I
    Ann Glob Health; 2023; 89(1):76. PubMed ID: 38025926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caring for Africa's sickle cell children: will we rise to the challenge?
    Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
    BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation.
    Byrnes C; Botello-Harbaum M; Clemons T; Bailey L; Valdes KM; Coleman-Cowger VH
    J Natl Med Assoc; 2022 Apr; 114(2):211-217. PubMed ID: 35093266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
    Tluway F; Makani J
    Br J Haematol; 2017 Jun; 177(6):919-929. PubMed ID: 28295224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
    Diallo DA; Guindo A
    Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa.
    Ally M; Balandya E
    Semin Hematol; 2023 Sep; 60(4):192-199. PubMed ID: 37730472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.
    Odame I; Kulkarni R; Ohene-Frempong K
    Am J Prev Med; 2011 Dec; 41(6 Suppl 4):S417-21. PubMed ID: 22099367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
    Babu BV; Sharma Y; Sridevi P; Surti SB; Bhat D; Ranjit M; Sudhakar G; Sarmah J
    Hemoglobin; 2023 Nov; 47(6):227-236. PubMed ID: 38189147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.
    Ruhl AP; Sadreameli SC; Allen JL; Bennett DP; Campbell AD; Coates TD; Diallo DA; Field JJ; Fiorino EK; Gladwin MT; Glassberg JA; Gordeuk VR; Graham LM; Greenough A; Howard J; Kato GJ; Knight-Madden J; Kopp BT; Koumbourlis AC; Lanzkron SM; Liem RI; Machado RF; Mehari A; Morris CR; Ogunlesi FO; Rosen CL; Smith-Whitley K; Tauber D; Terry N; Thein SL; Vichinsky E; Weir NA; Cohen RT; Klings ES
    Ann Am Thorac Soc; 2019 Sep; 16(9):e17-e32. PubMed ID: 31469310
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.
    Paintsil V; Amuzu EX; Nyanor I; Asafo-Adjei E; Mohammed AR; Yawnumah SA; Oppong-Mensah YG; Nguah SB; Obeng P; Dogbe EE; Jonas M; Nembaware V; Mazandu G; Ohene-Frempong K; Wonkam A; Makani J; Ansong D; Osei-Akoto A;
    Front Genet; 2022; 13():802355. PubMed ID: 35281803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo.
    Kambale-Kombi P; Marini Djang'eing'a R; Alworong'a Opara JP; Minon JM; Boemer F; Bours V; Tonen-Wolyec S; Kayembe Tshilumba C; Batina-Agasa S
    Hematology; 2021 Dec; 26(1):199-205. PubMed ID: 33594960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial considerations in sickle cell disease: patient-reported outcomes, data elements, and the stakeholder engagement framework.
    Badawy SM
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):196-205. PubMed ID: 34889394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease: current activities, public health implications, and future directions.
    Creary M; Williamson D; Kulkarni R
    J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease: new opportunities and challenges in Africa.
    Makani J; Ofori-Acquah SF; Nnodu O; Wonkam A; Ohene-Frempong K
    ScientificWorldJournal; 2013; 2013():193252. PubMed ID: 25143960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve tips for teaching a comprehensive disease-focused course with a global perspective: A sickle cell disease example.
    Bulgin D; Tanabe P; Asnani M; Royal CDM
    Med Teach; 2019 Mar; 41(3):275-281. PubMed ID: 29334305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.